Left ventricular decompression in paediatric veno-arterial extracorporeal life support: Reviewing the evidence

IF 3.7 2区 医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS
Giacomo Veronese, Paolo Meani, Domenico Sirico, Giovanni Di Salvo, Enrico Ammirati, Alessandro Varrica, Umberto Di Dedda, Paolo Bianchi, Giuseppe Isgrò, Alessandro Giamberti, Tommaso Aloisio, Marc Dickstein, Ezio Bonanomi, Bahaaldin Alsoufi, Ravi R. Thiagarajan, Peta M.A. Alexander, D. Michael McMullan, Ryan P. Barbaro, Graeme MacLaren, Marco Ranucci, Navin K. Kapur, Roberto Lorusso
{"title":"Left ventricular decompression in paediatric veno-arterial extracorporeal life support: Reviewing the evidence","authors":"Giacomo Veronese,&nbsp;Paolo Meani,&nbsp;Domenico Sirico,&nbsp;Giovanni Di Salvo,&nbsp;Enrico Ammirati,&nbsp;Alessandro Varrica,&nbsp;Umberto Di Dedda,&nbsp;Paolo Bianchi,&nbsp;Giuseppe Isgrò,&nbsp;Alessandro Giamberti,&nbsp;Tommaso Aloisio,&nbsp;Marc Dickstein,&nbsp;Ezio Bonanomi,&nbsp;Bahaaldin Alsoufi,&nbsp;Ravi R. Thiagarajan,&nbsp;Peta M.A. Alexander,&nbsp;D. Michael McMullan,&nbsp;Ryan P. Barbaro,&nbsp;Graeme MacLaren,&nbsp;Marco Ranucci,&nbsp;Navin K. Kapur,&nbsp;Roberto Lorusso","doi":"10.1002/ehf2.15325","DOIUrl":null,"url":null,"abstract":"<p>Veno-arterial extracorporeal life support (VA ECLS) is crucial for neonatal and paediatric patients with severe circulatory collapse but may cause left ventricular (LV) overload, affecting myocardial recovery and causing complications. Evidence on optimal LV decompression strategies in paediatric patients remains limited. We conducted a systematic review following PRISMA guidelines, including articles published between 1993 and 2024 focused on VA ECLS and LV decompression in patients under 18 years of age. The review included 11 retrospective cohorts and registry-based studies (2012–2024), totalling 1222 paediatric patients undergoing decompression. Patient demographics, initial diagnoses and VA ECLS settings were heterogeneous. The prevalence of LV decompression ranged from 46.6% in post-cardiotomy to 10.5% in non-post-cardiotomy peripheral VA ECLS cases. Most patients (57.1%) were supported with peripheral VA ECLS, and the majority (57.4%) underwent percutaneous decompression, whereas surgical approaches predominated in post-cardiotomy central VA ECLS. Balloon atrial septostomy (BAS) was the most frequent technique (50%), followed by surgically placed left atrial cannula (37.4%). Thirteen case series (70 patients) and 28 case reports (28 patients) were also reviewed. Substantial variability in LV decompression strategies exists based on age and clinical scenario. PAS-based techniques were more common in younger patients on peripheral VA ECLS while older children often underwent different strategies. Surgical approaches were preferred in central VA ECLS, particularly in the post-cardiotomy setting. Procedural safety varied by technique. While PAS-based strategies such as BAS generally showed low complication rates, adverse events like arrhythmia, bleeding and cardiac perforation were reported in 7%–9% of cases. Surgical LA cannulation was associated with higher bleeding risk. Impella use was linked to haemolysis (50%) and major bleeding (20%). Comparative data highlight that each technique carries distinct procedural risks and complication profiles. In conclusion, LV decompression during paediatric VA ECLS remains technically challenging and variably adopted. Its benefit appears more consistent in the post-cardiotomy setting, where improved survival and reduced adverse outcomes were observed. Given the lack of standardization, further prospective studies and collaborative registries are essential to guide strategy selection, timing and risk–benefit balance, particularly in such a vulnerable population.</p>","PeriodicalId":11864,"journal":{"name":"ESC Heart Failure","volume":"12 4","pages":"2711-2725"},"PeriodicalIF":3.7000,"publicationDate":"2025-05-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/ehf2.15325","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESC Heart Failure","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ehf2.15325","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Veno-arterial extracorporeal life support (VA ECLS) is crucial for neonatal and paediatric patients with severe circulatory collapse but may cause left ventricular (LV) overload, affecting myocardial recovery and causing complications. Evidence on optimal LV decompression strategies in paediatric patients remains limited. We conducted a systematic review following PRISMA guidelines, including articles published between 1993 and 2024 focused on VA ECLS and LV decompression in patients under 18 years of age. The review included 11 retrospective cohorts and registry-based studies (2012–2024), totalling 1222 paediatric patients undergoing decompression. Patient demographics, initial diagnoses and VA ECLS settings were heterogeneous. The prevalence of LV decompression ranged from 46.6% in post-cardiotomy to 10.5% in non-post-cardiotomy peripheral VA ECLS cases. Most patients (57.1%) were supported with peripheral VA ECLS, and the majority (57.4%) underwent percutaneous decompression, whereas surgical approaches predominated in post-cardiotomy central VA ECLS. Balloon atrial septostomy (BAS) was the most frequent technique (50%), followed by surgically placed left atrial cannula (37.4%). Thirteen case series (70 patients) and 28 case reports (28 patients) were also reviewed. Substantial variability in LV decompression strategies exists based on age and clinical scenario. PAS-based techniques were more common in younger patients on peripheral VA ECLS while older children often underwent different strategies. Surgical approaches were preferred in central VA ECLS, particularly in the post-cardiotomy setting. Procedural safety varied by technique. While PAS-based strategies such as BAS generally showed low complication rates, adverse events like arrhythmia, bleeding and cardiac perforation were reported in 7%–9% of cases. Surgical LA cannulation was associated with higher bleeding risk. Impella use was linked to haemolysis (50%) and major bleeding (20%). Comparative data highlight that each technique carries distinct procedural risks and complication profiles. In conclusion, LV decompression during paediatric VA ECLS remains technically challenging and variably adopted. Its benefit appears more consistent in the post-cardiotomy setting, where improved survival and reduced adverse outcomes were observed. Given the lack of standardization, further prospective studies and collaborative registries are essential to guide strategy selection, timing and risk–benefit balance, particularly in such a vulnerable population.

Abstract Image

左心室减压在小儿静脉-动脉体外生命支持:回顾证据。
静脉-动脉体外生命支持(VA ECLS)对于新生儿和儿童严重循环衰竭患者至关重要,但可能导致左心室(LV)过载,影响心肌恢复并引起并发症。关于儿科患者最佳左室减压策略的证据仍然有限。我们根据PRISMA指南进行了系统回顾,包括1993年至2024年间发表的关于18岁以下患者的VA ECLS和LV减压的文章。该综述包括11项回顾性队列和基于登记的研究(2012-2024),共1222例接受减压的儿科患者。患者人口统计学、初始诊断和VA ECLS设置是异质的。左室减压的发生率从心脏切开后的46.6%到非心脏切开后外周VA ECLS的10.5%不等。大多数患者(57.1%)支持外周VA ECLS,大多数患者(57.4%)接受经皮减压,而手术方式主要用于心脏切开术后的中央VA ECLS。球囊房间隔造口术(BAS)是最常见的技术(50%),其次是手术放置左心房插管(37.4%)。还回顾了13个病例系列(70例)和28个病例报告(28例)。根据年龄和临床情况,左室减压策略存在很大差异。基于pas的技术更常见于年轻的外周VA ECLS患者,而年龄较大的儿童通常采用不同的策略。手术入路是首选在中央VA ECLS,特别是在心脏切开术后设置。程序安全性因技术而异。虽然BAS等基于pas的策略通常显示出较低的并发症发生率,但7%-9%的病例报告了心律失常、出血和心脏穿孔等不良事件。手术LA插管与较高的出血风险相关。使用Impella与溶血(50%)和大出血(20%)有关。比较数据强调每种技术都有不同的手术风险和并发症。总之,在儿童VA ECLS期间左室减压在技术上仍然具有挑战性,并且采用的方法多种多样。它的益处在心脏切开术后更为一致,观察到生存率提高和不良后果减少。鉴于缺乏标准化,进一步的前瞻性研究和协作登记对于指导策略选择、时机选择和风险-收益平衡至关重要,特别是在这样一个弱势群体中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ESC Heart Failure
ESC Heart Failure Medicine-Cardiology and Cardiovascular Medicine
CiteScore
7.00
自引率
7.90%
发文量
461
审稿时长
12 weeks
期刊介绍: ESC Heart Failure is the open access journal of the Heart Failure Association of the European Society of Cardiology dedicated to the advancement of knowledge in the field of heart failure. The journal aims to improve the understanding, prevention, investigation and treatment of heart failure. Molecular and cellular biology, pathology, physiology, electrophysiology, pharmacology, as well as the clinical, social and population sciences all form part of the discipline that is heart failure. Accordingly, submission of manuscripts on basic, translational, clinical and population sciences is invited. Original contributions on nursing, care of the elderly, primary care, health economics and other specialist fields related to heart failure are also welcome, as are case reports that highlight interesting aspects of heart failure care and treatment.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信